Orchid Pharma [ORCHPHARMA] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Orchid Pharma

NSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Orchid Pharma wins in 5 metrics, Aarti Drugs wins in 14 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricOrchid PharmaAarti DrugsBetter
P/E Ratio (TTM)42.8423.66Aarti Drugs
Price-to-Book Ratio2.883.26Orchid Pharma
Debt-to-Equity Ratio13.7844.92Orchid Pharma
PEG Ratio-0.870.37Orchid Pharma
EV/EBITDA36.7117.07Aarti Drugs
Profit Margin (TTM)10.02%7.80%Orchid Pharma
Operating Margin (TTM)3.19%10.11%Aarti Drugs
EBITDA Margin (TTM)3.19%10.11%Aarti Drugs
Return on Equity7.86%12.28%Aarti Drugs
Return on Assets (TTM)5.90%6.53%Aarti Drugs
Free Cash Flow (TTM)$-1.31B$674.22MAarti Drugs
Dividend YieldN/A0.22%N/A
1-Year Return-43.92%-5.48%Aarti Drugs
Price-to-Sales Ratio (TTM)4.291.84Aarti Drugs
Enterprise Value$36.47B$50.47BAarti Drugs
EV/Revenue Ratio4.292.08Aarti Drugs
Gross Profit Margin (TTM)42.83%36.77%Orchid Pharma
Revenue per Share (TTM)$168$265Aarti Drugs
Earnings per Share (Diluted)$16.81$20.63Aarti Drugs
Beta (Stock Volatility)1.730.12Aarti Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Orchid Pharma vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Orchid Pharma
Aarti Drugs
Orchid Pharma Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Orchid Pharma3.31%-2.46%-1.19%-2.62%-8.02%-60.77%
Aarti Drugs0.73%-5.64%3.08%3.92%42.25%7.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Orchid Pharma-43.92%118.62%13,113.76%1,051.32%155.69%167.61%
Aarti Drugs-5.48%-1.60%-50.42%217.00%2,669.86%2,850.73%

News Based Sentiment: Orchid Pharma vs Aarti Drugs

Orchid Pharma

News based Sentiment: MIXED

September was a month of contrasting signals for Orchid Pharma. While the company demonstrated improved profitability in its Q4 results and maintained positive analyst ratings, concerns about falling cash flow and stock price volatility create a mixed investment picture. The merger with Dhanuka Laboratories, mentioned in previous reports, continues to be a key factor for long-term growth.

View Orchid Pharma News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Orchid Pharma vs Aarti Drugs

MetricORCHPHARMAAARTIDRUGS
Market Information
Market Cap i₹37.30B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i242,245201,942
90 Day Avg. Volume i111,640187,563
Last Close₹744.00₹491.60
52 Week Range₹603.80 - ₹1,997.40₹312.00 - ₹564.05
% from 52W High-62.75%-12.84%
All-Time High₹2,654.25 (Apr 05, 2021)₹1,026.95 (Oct 05, 2020)
% from All-Time High-71.97%-52.13%
Growth Metrics
Quarterly Revenue Growth-0.29%0.06%
Quarterly Earnings Growth-0.49%0.62%
Financial Health
Profit Margin (TTM) i0.10%0.08%
Operating Margin (TTM) i0.03%0.10%
Return on Equity (TTM) i0.08%0.12%
Debt to Equity (MRQ) i13.7844.92
Cash & Liquidity
Book Value per Share (MRQ)₹250.11₹149.84
Cash per Share (MRQ)₹35.44₹2.48
Operating Cash Flow (TTM) i₹-82,697,000₹2.83B
Levered Free Cash Flow (TTM) i₹996.57M₹1.68B
Dividends
Last 12-Month Dividend Yield iN/A0.22%
Last 12-Month Dividend i₹0.00₹1.00

Valuation & Enterprise Metrics Analysis: Orchid Pharma vs Aarti Drugs

MetricORCHPHARMAAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i42.8423.66
Forward P/E i22.3115.02
PEG Ratio i-0.870.37
Price to Sales (TTM) i4.291.84
Price to Book (MRQ) i2.883.26
Market Capitalization
Market Capitalization i₹37.30B₹44.55B
Enterprise Value i₹36.47B₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i4.292.08
Enterprise to EBITDA i36.7117.07
Risk & Other Metrics
Beta i1.730.12
Book Value per Share (MRQ) i₹250.11₹149.84

Financial Statements Comparison: Orchid Pharma vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ORCHPHARMAAARTIDRUGS
Revenue/Sales i₹1.73B₹5.91B
Cost of Goods Sold i₹988.65M₹3.73B
Gross Profit i₹740.63M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹55.21M₹593.60M
EBITDA i₹256.23M₹743.90M
Pre-Tax Income i₹137.11M₹511.10M
Income Tax i₹0₹-28.60M
Net Income (Profit) i₹149.11M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ORCHPHARMAAARTIDRUGS
Cash & Equivalents i₹211.07M₹45.77M
Total Current Assets i₹8.07B₹13.38B
Total Current Liabilities i₹2.86B₹8.37B
Long-Term Debt i₹1.32B₹2.86B
Total Shareholders Equity i₹12.67B₹13.69B
Retained Earnings i₹-20.78B₹12.40B
Property, Plant & Equipment i₹166.44M₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ORCHPHARMAAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricORCHPHARMAAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i242,245201,942
Average Daily Volume (90 Day) i111,640187,563
Shares Outstanding i50.72M91.27M
Float Shares i15.30M39.04M
% Held by Insiders i0.70%0.60%
% Held by Institutions i0.18%0.11%

Dividend Analysis & Yield Comparison: Orchid Pharma vs Aarti Drugs

MetricORCHPHARMAAARTIDRUGS
Last 12-Month Dividend i₹0.00₹1.00
Last 12-Month Dividend Yield iN/A0.22%
3-Year Avg Annual Dividend i₹0.00₹1.00
3-Year Avg Dividend Yield iN/A0.23%
3-Year Total Dividends i₹0.00₹3.00
Ex-Dividend DateN/AFeb 04, 2025